Microbot Medical Analyst Ratings
Microbot Medical Analyst Ratings
| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 10/18/2023 | 429.8% | HC Wainwright & Co. | → $8 | Reiterates | Buy → Buy |
| 06/26/2023 | 429.8% | HC Wainwright & Co. | → $8 | Reiterates | Buy → Buy |
| 06/06/2023 | 429.8% | HC Wainwright & Co. | → $8 | Reiterates | → Buy |
| 05/09/2023 | 429.8% | HC Wainwright & Co. | $20 → $8 | Maintains | Buy |
| 08/18/2020 | 1224.5% | HC Wainwright & Co. | $19 → $20 | Maintains | Buy |
| 01/13/2020 | 1621.85% | HC Wainwright & Co. | $12 → $26 | Reiterates | → Buy |
| 12/24/2019 | 694.7% | HC Wainwright & Co. | $10 → $12 | Reiterates | → Buy |
| 07/22/2019 | 562.25% | HC Wainwright & Co. | → $10 | Initiates Coverage On | → Buy |
| 11/19/2018 | — | Ladenburg Thalmann | Downgrades | Buy → Neutral |
| 日期 | 上行/下行 | 分析師事務所 | 目標價格變動 | 評級變動 | 之前/當前的評級 |
|---|---|---|---|---|---|
| 2023 年 10 月 18 日 | 429.8% | HC Wainwright & Co. | → 8 美元 | 重申 | 購買 → 購買 |
| 06/26/2023 | 429.8% | HC Wainwright & Co. | → 8 美元 | 重申 | 購買 → 購買 |
| 06/06/2023 | 429.8% | HC Wainwright & Co. | → 8 美元 | 重申 | → 購買 |
| 05/09/2023 | 429.8% | HC Wainwright & Co. | 20 美元 → 8 美元 | 維護 | 買 |
| 08/18/2020 | 1224.5% | HC Wainwright & Co. | 19 美元 → 20 美元 | 維護 | 買 |
| 2020 年 1 月 13 日 | 1621.85% | HC Wainwright & Co. | 12 美元 → 26 美元 | 重申 | → 購買 |
| 12/24/2019 | 694.7% | HC Wainwright & Co. | 10 美元 → 12 美元 | 重申 | → 購買 |
| 07/22/2019 | 562.25% | HC Wainwright & Co. | → 10 美元 | 啓動覆蓋範圍開啓 | → 購買 |
| 11/19/2018 | — | 拉登堡塔爾曼 | 降級 | 買入 → 中性 |
What is the target price for Microbot Medical (MBOT)?
微機器人醫療（MBOT）的目標價格是多少？
The latest price target for Microbot Medical (NASDAQ: MBOT) was reported by HC Wainwright & Co. on October 18, 2023. The analyst firm set a price target for $8.00 expecting MBOT to rise to within 12 months (a possible 429.80% upside). 4 analyst firms have reported ratings in the last year.
HC Wainwright & Co. 於2023年10月18日公佈了Microbot Medical（納斯達克股票代碼：MBOT）的最新目標股價。該分析公司將目標股價設定爲8.00美元，預計MBOT將在12個月內上漲至8美元（可能上漲429.80％）。去年有4家分析公司公佈了評級。
What is the most recent analyst rating for Microbot Medical (MBOT)?
微機器人醫療（MBOT）的最新分析師評級是多少？
The latest analyst rating for Microbot Medical (NASDAQ: MBOT) was provided by HC Wainwright & Co., and Microbot Medical reiterated their buy rating.
Microbot Medical（納斯達克股票代碼：MBOT）的最新分析師評級由HC Wainwright & Co. 提供，Microbot Medical重申了他們的買入評級。
When is the next analyst rating going to be posted or updated for Microbot Medical (MBOT)?
Microbot Medical（MBOT）的下一個分析師評級何時發佈或更新？
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Microbot Medical, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Microbot Medical was filed on October 18, 2023 so you should expect the next rating to be made available sometime around October 18, 2024.
分析師在進行了廣泛的研究後得出了股票評級，其中包括瀏覽公開財務報表，與Microbot Medical的高管和客戶交談，以及聽取業績電話會議。大多數分析師每三個月進行一次評級，因此每家公司每年應獲得4個評級。Microbot Medical的最後一次評級是在2023年10月18日提交的，因此您應該預計下一個評級將在2024年10月18日左右公佈。
Is the Analyst Rating Microbot Medical (MBOT) correct?
分析師對 Microbot Medical (MBOT) 的評級是否正確？
While ratings are subjective and will change, the latest Microbot Medical (MBOT) rating was a reiterated with a price target of $0.00 to $8.00. The current price Microbot Medical (MBOT) is trading at is $1.51, which is within the analyst's predicted range.
儘管評級是主觀的，並將發生變化，但最新的微機器人醫療（MBOT）評級得到了重申，目標股價爲0.00美元至8.00美元。Microbot Medical（MBOT）目前的交易價格爲1.51美元，在分析師的預測區間內。
譯文內容由第三人軟體翻譯。